These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3672160)

  • 1. [Hyperlipoproteinemias].
    Chanu B
    Soins; 1987 Jul; (502):7-12. PubMed ID: 3672160
    [No Abstract]   [Full Text] [Related]  

  • 2. [HDL, HDL2 and HDL3 cholesterol in various types of hyperlipoproteinemia in relation to clinical signs of arteriosclerosis].
    Sznajderman M; Zawadzki Z
    Kardiol Pol; 1986; 29(3):194-203. PubMed ID: 3773408
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolytic capacity after exertion in atherogenic hyperlipoproteinemias].
    Zdrenghea D; Mărcuşu C; Cucuianu M; Rentsch S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):435-40. PubMed ID: 44567
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta 2 glycoprotein I analysis in patients with hyperlipoproteinemia, arteriosclerotic occlusive disease and diabetes mellitus].
    Müller G; Biering A; Lux E; Richter V
    Z Gesamte Inn Med; 1983 May; 38(10):282-4. PubMed ID: 6613192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary hyperlipoproteinemias--pathophysiology, clinical aspects and genetics].
    Keller C; Zöllner N
    Internist (Berl); 1992 Jan; 33(1):9-15. PubMed ID: 1551767
    [No Abstract]   [Full Text] [Related]  

  • 6. Can genes prevent atherosclerosis?
    Hoeg JM
    JAMA; 1996 Sep; 276(12):989-92. PubMed ID: 8805735
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lipoprotein receptors and dyslipoproteinemias].
    Orbetsova V
    Vutr Boles; 1984; 23(3):1-7. PubMed ID: 6087571
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary familial hyper-alpha-lipoproteinemia in Israel].
    Raveh D; Israeli A; Gavish D; Eisenberg S
    Harefuah; 1986 Nov; 111(10):285-7. PubMed ID: 3817613
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of phospholipids in primary hyperlipoproteinemias].
    Kuczyńska K
    Pol Arch Med Wewn; 1979 Jul; 62(1):29-40. PubMed ID: 503884
    [No Abstract]   [Full Text] [Related]  

  • 11. Behaviour of platelet adhesiveness and of dilute clot blood lysis time in hyperlipoproteinemic subjects.
    Zdrenghea D; Stef C; Cucuianu M; Vlaicu R
    Med Interne; 1979; 17(3):273-7. PubMed ID: 504931
    [No Abstract]   [Full Text] [Related]  

  • 12. [How should primary hyperlipoproteinemia be classified?].
    Rubiés-Prat J
    Med Clin (Barc); 1983 May; 80(19):836-8. PubMed ID: 6888036
    [No Abstract]   [Full Text] [Related]  

  • 13. The hyperlipoproteinemias.
    Crepaldi G; Baggio G; Manzato E
    Ann Ital Med Int; 1986; 1 Suppl 1():1-5. PubMed ID: 3079432
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperlipoproteinemia as the cause of increased plasma antiheparin activity in patients with arteriosclerosis].
    Rółkowski R; Worowski K; Skrzydlewski Z; Głowiński S
    Kardiol Pol; 1986; 29(3):204-8. PubMed ID: 3773409
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperbetalipoproteinaemia and hyperalphalipoproteinaemia in a single family.
    Nye ER; Harding DR; Hancock WS; Janus ED
    N Z Med J; 1983 Feb; 96(725):85-8. PubMed ID: 6571965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial disorders of lipid metabolism in childhood].
    Herrmann W; Biermann J
    Z Arztl Fortbild (Jena); 1986; 80(17):725-8. PubMed ID: 3811401
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects of hyperlipoproteinemia (author's transl)].
    Kaffarnik H; Schneider J
    Ther Umsch; 1980 Nov; 37(11):973-9. PubMed ID: 7455962
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
    Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C
    Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Apolipoprotein E polymorphism, hyperlipidemia and risk of myocardial infarct].
    Assmann G; Lenzen HJ
    Internist (Berl); 1985 Nov; 26(11):692-700. PubMed ID: 3908375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.